Drug · DIN 02332019
SIMVASTATIN TABLETS
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since July 10, 2025.
- Drug Identification Number (DIN)
- 02332019
- Company (DIN owner)
- Ranbaxy Pharmaceuticals Canada Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Simvastatin C10AA01
- Class
- Human
- Record last updated
- July 11, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SIMVASTATIN | 80 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 24, 2009: NOC 10536Abbreviated New Drug Submission (ANDS) · Additional product name
Other DINs named SIMVASTATIN TABLETS
- DIN 02331969 · Cancelled Pre Market
- DIN 02331985 · Cancelled Pre Market
- DIN 02331993 · Cancelled Pre Market
- DIN 02332000 · Cancelled Pre Market